Latest Technology News

Macquarie Technology Group has landed a significant A$200 million hybrid capital injection from the Australian Government-backed National Reconstruction Fund Corporation, aimed at boosting sovereign digital infrastructure and cybersecurity services.

TZ Limited has responded to ASX queries over the deferral of a A$2.75 million debt repayment, asserting the delay was already well disclosed and unlikely to impact its share price materially.

King River Resources is deploying cutting-edge geophysical and digital mapping technologies at its historically rich Mindoolah Gold Project, aiming to unlock new high-grade gold targets with unprecedented precision.

Adherium Limited reports a strong uptick in Remote Patient Monitoring revenue and device activations, driven by new reimbursement codes and strategic partnerships, aiming for 10,000 RPM patients by year-end.

Aerometrex has won multiple government contracts worth $2.5 million over three years, reinforcing its position as a trusted local provider and enhancing revenue visibility.

HighCom Limited has successfully raised nearly $800,000 through a Share Purchase Plan, adding to a prior $7 million placement to fund product upgrades and sales growth.

Victory Metals Limited has reported a record-breaking rare earth oxide intersection of 11,565 ppm TREO at its North Stanmore project, reinforcing its status as a world-class heavy rare earth deposit. The December 2025 drilling program also advances resource confidence and metallurgical prospects, positioning the project as a key Western supplier of critical rare earths.

Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.

St George Mining has appointed Carla Grasso as Principal Geologist to spearhead mine planning at its Araxá Rare Earths-Niobium Project, following a major resource upgrade. This move signals a decisive step towards advancing economic studies and potential mining operations in Brazil.

Orica reports solid first-half earnings growth led by digital and specialty chemicals, while launching a $100 million cost reduction program to navigate supply disruptions and litigation headwinds.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Clarity Pharmaceuticals has completed enrolment in its Phase III AMPLIFY trial for the Cu-SAR-bisPSMA imaging agent, advancing its bid for FDA approval in prostate cancer diagnostics.